LAVANYA SUNDARARAJAN, MD
Medical Oncology Physician in TACOMA, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
LAVANYA SUNDARARAJAN, MD filed 626 Medicare Part D claims in 2023 as a Medical Oncology Physician in TACOMA, Washington, prescribing 63% generic.
- 626
- Part D claims, 2023
- 63%
- generic prescribing
- $85.97
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
LAVANYA SUNDARARAJAN, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
626 Top 31% higher than 69% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
LAVANYA SUNDARARAJAN, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about LAVANYA SUNDARARAJAN, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Washington
How Medical Oncology Physician compares to other specialties among Washington providers
Medical Oncology Physician share within Washington
Medical Oncology Physician is one of the more visible NUCC categories in Washington
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Medical Oncology Physician ABMS/AOA estimate
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Medical Oncology Physician US NPIs
Specialty board-certified rate — Medical Oncology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
LAVANYA SUNDARARAJAN, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 1617 SOUTH J. ST, TACOMA, WA, 98405, with a listed phone of (253) 426-4297. NPI 1568553097 was issued on 09/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SUNDARARAJAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 626 prescription claims written by this provider, covering 110 Medicare beneficiaries and totaling roughly $2.1 million in drug spend, split 37% brand-name and 63% generic by claim count, with an opioid prescribing rate of 6.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1568553097 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 09/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm LAVANYA SUNDARARAJAN, MD's current license status, disciplinary history, and board certifications with the Washington State Department of Health, Medical Quality Assurance Commission in Washington before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LAVANYA SUNDARARAJAN, MD. Source: openpaymentsdata.cms.gov.
Total received
$86
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Washington WMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to LAVANYA SUNDARARAJAN, MD. To verify LAVANYA SUNDARARAJAN, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
37% brand-name claims vs 63% generic, on 626 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 904
- Total Day Supply
- 24,802
- Brand vs Generic
- 37% brand / 63% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $126K
- Opioid Claims
- 38 (6.1% rate)
- Antibiotic Claims
- 26
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 1.94
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 12, 65-74: 52, 75-84: 32, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What LAVANYA SUNDARARAJAN, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Xarelto
Xarelto
59 claims
- Hydroxyurea
Hydroxyurea
52 claims
- Calquence
Calquence
39 claims
- Eliquis
Eliquis
36 claims
- Letrozole
Letrozole
33 claims
- Oxycodone Hcl
Oxycodone Hcl
24 claims
- Acyclovir 18
Acyclovir
18 claims
- Jakafi 18
Jakafi
18 claims
| Drug | Claims |
|---|---|
| Xarelto Rivaroxaban | 59 |
| Hydroxyurea | 52 |
| Calquence Acalabrutinib Maleate | 39 |
| Eliquis Apixaban | 36 |
| Letrozole | 33 |
| Oxycodone Hcl | 24 |
| Acyclovir | 18 |
| Jakafi Ruxolitinib Phosphate | 18 |
| Anastrozole | 15 |
| Metoprolol Tartrate | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How LAVANYA SUNDARARAJAN, MD fits within the Medical Oncology Physician landscape nationally.
LAVANYA SUNDARARAJAN, MD's 626 claims are below the specialty average of 689.
Nearby Medical Oncology Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as SUNDARARAJAN.
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Washington
Frequently Asked Questions
What is LAVANYA SUNDARARAJAN, MD's specialty? ▼
How much does LAVANYA SUNDARARAJAN, MD prescribe under Medicare Part D? ▼
Where is LAVANYA SUNDARARAJAN, MD located? ▼
What is LAVANYA SUNDARARAJAN, MD's NPI number? ▼
Does LAVANYA SUNDARARAJAN, MD prescribe more brand-name or generic drugs? ▼
Does LAVANYA SUNDARARAJAN, MD prescribe opioids? ▼
How many Medical Oncology Physician providers are there in the US? ▼
What drugs does LAVANYA SUNDARARAJAN, MD prescribe most often? ▼
Does LAVANYA SUNDARARAJAN, MD accept Medicare? ▼
How can I verify LAVANYA SUNDARARAJAN, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology